|
D-myo-Ins(1,4,5)P3 hexakis(butyryloxymethyl) ester |
|
CHEBI:138527 |
|
D-myo-Ins(1,4,5)P3 hexakis(butyryloxymethyl) ester |
|
A phosphatidylinositol trisphosphate that is 1D-myo-inositol 1,4,5-trisphosphate in which all all six phosphate hydrogens have been replaced by butyryloxymethyl groups. It is a cell-permeant analogue of inositol 1,4,5-trisphosphate and an agonist of the inositol 1,4,5-trisphosphate receptor. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Sabrina Toro
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C36H63O27P3/c1-7-13-25(37)49-19-55-64(46,56-20-50-26(38)14-8-2)61-34-31(43)32(44)35(62-65(47,57-21-51-27(39)15-9-3)58-22-52-28(40)16-10-4)36(33(34)45)63-66(48,59-23-53-29(41)17-11-5)60-24-54-30(42)18-12-6/h31-36,43-45H,7-24H2,1-6H3/t31-,32+,33+,34-,35-,36-/m1/s1 |
PVEVFIAVCISJSO-FOJCDXFYSA-N |
[C@@H]1([C@@H]([C@@H](O)[C@H]([C@H]([C@@H]1O)OP(=O)(OCOC(=O)CCC)OCOC(=O)CCC)O)OP(=O)(OCOC(=O)CCC)OCOC(=O)CCC)OP(=O)(OCOC(=O)CCC)OCOC(=O)CCC |
|
IP3 receptor agonist
An agonist that activates IP3 receptors.
|
|
View more via ChEBI Ontology
Outgoing
|
D-myo-Ins(1,4,5)P3 hexakis(butyryloxymethyl) ester
(CHEBI:138527)
has functional parent
1D-myo-inositol 1,4,5-trisphosphate
(CHEBI:16595)
D-myo-Ins(1,4,5)P3 hexakis(butyryloxymethyl) ester
(CHEBI:138527)
has role
IP3 receptor agonist
(CHEBI:139109)
D-myo-Ins(1,4,5)P3 hexakis(butyryloxymethyl) ester
(CHEBI:138527)
is a
phosphatidylinositol trisphosphate
(CHEBI:60169)
|
|
[(1R,2R,3S,4R,5R,6S)-3,5,6-trihydroxycyclohexane-1,2,4-triyl]tris[oxyphosphorylbis(oxymethylene)] hexabutanoate
|
[(1R,2R,3S,4R,5R,6S)-3,5,6-trihydroxycyclohexane-1,2,4-triyl]tris[oxyphosphorylbis(oxymethylene)] hexabutyrate
|
(−)-1D-myo-inositol 1,4,5-triphosphate hexakis(butyryloxymethyl) ester
|
ChEBI
|
D-myo-Ins(1,4,5)P3 hexakis(butanoyloxymethyl) ester
|
ChEBI
|
IP3/BM
|
ChEBI
|
10757630
|
Reaxys Registry Number
|
Reaxys
|
209479-81-2
|
CAS Registry Number
|
SUBMITTER
|
12522076
|
PubMed citation
|
Europe PMC
|
28390800
|
PubMed citation
|
Europe PMC
|
|